Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06748911 · ClinicalTrials.gov registry record · NA
Navicam for Detection of Barrett's Esophagus
A NA study of Barrett's Esophagus, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT06748911: Recruiting NA study of Barrett's Esophagus, sponsored by Mayo Clinic.
NCT06748911 is a NA study of Barrett's Esophagus that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 57 participants, below the 522-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06748911, a NA study of Barrett's Esophagus, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a non-invasive capsule system to achieve optimal viewing angles of the esophagus for detection of Barrett's esophagus
Primary Outcome
Detection of Columnar lined epithelium in the esophagus
Conditions Studied
Interventions
- DEVICE NaviCam Detachable String Capsule
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2025-02-20 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT06748911 shows while recruiting
NCT06748911 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 522-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Barrett's Esophagus appearing as the primary indexed condition, and to 1 intervention - of which NaviCam Detachable String Capsule is the first listed.
NCT06748911 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06748911 about?
NCT06748911 is a clinical study titled "Navicam for Detection of Barrett's Esophagus". Using a non-invasive capsule system to achieve optimal viewing angles of the esophagus for detection of Barrett's esophagus
What is the current status of trial NCT06748911?
This trial is currently recruiting. It is a NA study. The enrollment target is 57 participants. The study started on 2025-02-20. Estimated completion is 2026-05.
What conditions does trial NCT06748911 study?
This clinical trial studies the following conditions: Barrett's Esophagus.
What interventions are being tested in trial NCT06748911?
The interventions under investigation include: NaviCam Detachable String Capsule (DEVICE).
Who is sponsoring clinical trial NCT06748911?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06748911 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06748911's enrollment target sits among peer trials
57 15th of 22 higher than 8 of 22 other Barrett's Esophagus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Barrett's Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
RECRUITING · NA
-
Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule
ACTIVE NOT RECRUITING · NA
-
Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
COMPLETED · NA
-
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
COMPLETED · NA
-
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
COMPLETED · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI